Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein
暂无分享,去创建一个
E. Masliah | Seokjoong Kim | S. Sardi | He-Jin Lee | Eun-Jin Bae | Seung-Jae Lee | Byung Chul Jung | N. Yang | Miyoung Song | Cheolsoon Lee | Jun Sung Lee | He‐Jin Lee
[1] P. Brundin,et al. Alpha‐synuclein transfers from neurons to oligodendrocytes , 2014, Glia.
[2] He-Jin Lee,et al. Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases , 2014, Nature Reviews Neurology.
[3] M. Nalls,et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. , 2013, JAMA neurology.
[4] E. Masliah,et al. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia , 2013, Nature Communications.
[5] M. Ban,et al. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. , 2013, Brain : a journal of neurology.
[6] E. Masliah,et al. Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission , 2012, The Journal of Neuroscience.
[7] J. Hardy,et al. Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains , 2012, Annals of neurology.
[8] A. Winslow,et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers , 2012, Molecular Neurodegeneration.
[9] A. Björklund,et al. Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo , 2012, PloS one.
[10] K. Marder,et al. Cognitive performance of GBA mutation carriers with early-onset PD , 2012, Neurology.
[11] Y. Yun,et al. Enzyme-linked immunosorbent assays for alpha-synuclein with species and multimeric state specificities , 2011, Journal of Neuroscience Methods.
[12] R. Sidman,et al. CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy , 2011, Proceedings of the National Academy of Sciences.
[13] Jennifer C. Lee,et al. α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases* , 2011, The Journal of Biological Chemistry.
[14] E. Masliah,et al. Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease , 2011, PloS one.
[15] Igor Tsigelny,et al. Cell-to-cell transmission of non-prion protein aggregates , 2010, Nature Reviews Neurology.
[16] T. Outeiro,et al. Zooming into protein oligomerization in neurodegeneration using BiFC. , 2010, Trends in biochemical sciences.
[17] Ji-Eun Suk,et al. Non‐classical exocytosis of α‐synuclein is sensitive to folding states and promoted under stress conditions , 2010, Journal of neurochemistry.
[18] Ronald Melki,et al. Prion-like transmission of protein aggregates in neurodegenerative diseases , 2010, Nature Reviews Molecular Cell Biology.
[19] E. Masliah,et al. Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies* , 2010, The Journal of Biological Chemistry.
[20] Brian Spencer,et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.
[21] K. Marder,et al. Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.
[22] Tianhong Pan,et al. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. , 2008, Brain : a journal of neurology.
[23] Bradley T. Hyman,et al. Formation of Toxic Oligomeric α-Synuclein Species in Living Cells , 2008, PloS one.
[24] M. Horowitz,et al. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. , 2007, Human molecular genetics.
[25] P. Kahle. α-Synucleinopathy models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.
[26] Jonathan Salcedo,et al. Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein , 2004, The Journal of Neuroscience.
[27] He-Jin Lee,et al. Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway , 2004, The Journal of Neuroscience.
[28] K. Jellinger,et al. α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study , 2003, Acta Neuropathologica.
[29] Seung-Jae Lee,et al. Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. , 2002, The Journal of biological chemistry.
[30] Makoto Hashimoto,et al. Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promoters , 2002, Journal of neuroscience research.
[31] E. Masliah,et al. α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.
[32] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[33] J. Stockman. Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .
[34] He-Jin Lee,et al. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. , 2008, The international journal of biochemistry & cell biology.
[35] P. Kahle. alpha-Synucleinopathy models and human neuropathology: similarities and differences. , 2008, Acta neuropathologica.
[36] Gudrun Wacker. Similarities and Differences , 2005 .
[37] M. Chesselet,et al. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] He-Jin Lee,et al. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[39] K. Jellinger. α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study , 2003, Acta Neuropathologica.
[40] E. Masliah,et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.
[41] R A Crowther,et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.